These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23207657)

  • 1. Transjugular intrahepatic portosystemic shunt for treatment of cirrhosis-related chylothorax and chylous ascites: single-institution retrospective experience.
    Kikolski SG; Aryafar H; Rose SC; Roberts AC; Kinney TB
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):992-7. PubMed ID: 23207657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis.
    Kinney TB; Ferrara SL; Miller FJ; Roberts AC; Hassanein T
    J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):85-9. PubMed ID: 14709693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Chylothorax and Chylous Ascites in Cirrhosis: A Case Report and Systematic Review of the Literature.
    Tsauo J; Shin JH; Han K; Yoon HK; Ko GY; Ko HK; Gwon DI
    J Vasc Interv Radiol; 2016 Jan; 27(1):112-6. PubMed ID: 26723922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory Chylous Ascites with Chylothorax and an Umbilical Hernia in a Patient Ineligible for a Transjugular Intrahepatic Portosystemic Shunt.
    Fatah A; Audiyanto T
    Am J Case Rep; 2020 Aug; 21():e925026. PubMed ID: 32865187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
    Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
    Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
    Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
    N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cirrhosis related chylous ascites successfully treated with TIPS.
    de Vries GJ; Ryan BM; de Bièvre M; Driessen A; Stockbrugger RW; Koek GH
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):463-6. PubMed ID: 15756102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chylous ascites in cirrhosis. Retrospective study of 20 cases].
    Sultan S; Pauwels A; Poupon R; Lévy VG
    Gastroenterol Clin Biol; 1990; 14(11):842-7. PubMed ID: 2177427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney.
    Hamel B; Guillaud O; Roman S; Vallin M; Pilleul F; Valette PJ; Henry L; Guibal A; Mion F; Dumortier J
    Dig Liver Dis; 2014 Nov; 46(11):1001-7. PubMed ID: 25096966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIPS (transjugular intrahepatic portosystemic shunt): state of art and personal experience.
    Ugolotti U; Larini P; Marcato C; Saccani A; Pedretti G
    Acta Biomed Ateneo Parmense; 1996; 67(3-4):143-9. PubMed ID: 10021697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial.
    Riggio O; Ridola L; Angeloni S; Cerini F; Pasquale C; Attili AF; Fanelli F; Merli M; Salvatori FM
    J Hepatol; 2010 Aug; 53(2):267-72. PubMed ID: 20537753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis.
    Lutz P; Strunk H; Schild HH; Sauerbruch T
    World J Gastroenterol; 2013 Feb; 19(7):1140-2. PubMed ID: 23467463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.
    Gaba RC; Parvinian A; Casadaban LC; Couture PM; Zivin SP; Lakhoo J; Minocha J; Ray CE; Knuttinen MG; Bui JT
    Clin Radiol; 2015 May; 70(5):e51-7. PubMed ID: 25758602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
    Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
    Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.